| # | Drug | Count |
|---|---|---|
| 0 | RITONAVIR | 28 |
| 1 | LAMIVUDINE AND ZIDOVUDINE | 22 |
| 2 | ZIDOVUDINE | 18 |
| 3 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 17 |
| 4 | ATAZANAVIR | 16 |
| 5 | LOPINAVIR AND RITONAVIR | 15 |
| 6 | RITONAVIR 100 MG | 12 |
| 7 | DARUNAVIR | 7 |
| 8 | NELFINAVIR MESYLATE | 6 |
| 9 | SORAFENIB | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NELFINAVIR MESYLATE | 6 | 0.0029 |
| 1 | LAMIVUDINE AND ZIDOVUDINE | 22 | 0.0029 |
| 2 | ZIDOVUDINE | 18 | 0.0017 |
| 3 | ATAZANAVIR | 16 | 0.0011 |
| 4 | LOPINAVIR AND RITONAVIR | 15 | 0.0011 |
| 5 | RITONAVIR 100 MG | 12 | 0.0008 |
| 6 | DARUNAVIR 600 MG | 3 | 0.0005 |
| 7 | DARUNAVIR | 7 | 0.0005 |
| 8 | RALTEGRAVIR | 2 | 0.0004 |
| 9 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 17 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 40 | 0.0009 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 40 | 0.0007 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 26 | 0.0005 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 42 | 0.0004 |
| 4 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 6 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 6 | 0.0001 |
| 7 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 8 | Hepatitis C Virus NS5A Inhibitor [EPC] | 4 | 0.0001 |
| 9 | Nucleoside Analog Antiviral [EPC] | 5 | 0.0001 |